Flap Vs Flapless Technique for Delayed Implant Placement in the Maxillary Esthetic Zone
Assessment of Flap Versus Flapless Technique for Delayed Implant Placement in The Maxillary Esthetic Zone
1 other identifier
interventional
16
1 country
1
Brief Summary
This randomized comparative clinical trial aims to evaluate the clinical, radiographic, and esthetic outcomes of flap versus flapless techniques for delayed dental implant placement in the maxillary esthetic zone. Sixteen patients requiring implant placement in the maxillary anterior or premolar region will be randomly allocated into two equal groups. Group I will undergo implant placement using the conventional flap technique, while Group II will receive implant placement using the flapless technique. Clinical outcomes including postoperative pain, edema, surgical insertion time, and implant stability will be assessed. Radiographic evaluation will include peri-implant bone quantity, bone quality, and crestal bone loss. Follow-up examinations will be performed immediately after surgery and at 1, 3 and 6 months postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2026
CompletedFirst Submitted
Initial submission to the registry
June 12, 2026
CompletedFirst Posted
Study publicly available on registry
June 17, 2026
CompletedJune 17, 2026
June 1, 2026
1.2 years
June 12, 2026
June 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Implant Stability Quotient (ISQ)
Implant stability measured using the Osstell resonance frequency analysis device.
Immediately after implant placement and 6 months postoperatively.
Marginal Crestal Bone Loss
Radiographic assessment of peri-implant crestal bone level changes using standardized digital periapical radiographs.
Immediately postoperative, 1 month, 3 months, and 6 months.
Relative bone density
Radiographic assessment of peri-implant bone density using standardized digital periapical radiographs.
Immediately postoperative, 1 month, 3 months, and 6 months.
Secondary Outcomes (4)
Postoperative Pain
Postoperative days 1, 3, and 7.
Postoperative Edema
Postoperative days 1,3 and 7.
Surgical Insertion Time
During surgery.
Postoperative Comfort
1 day postoperatively
Study Arms (2)
Flap Technique
EXPERIMENTALDelayed implant placement using a conventional full-thickness mucoperiosteal flap approach.
Flapless Technique
EXPERIMENTALDelayed implant placement using a flapless surgical approach.
Interventions
Implant placement following crestal incision and mucoperiosteal flap elevation to expose the alveolar ridge.
Implant placement performed without flap elevation using a minimally invasive flapless approach.
Eligibility Criteria
You may qualify if:
- Patients aged from 30 to 50 years old.
- Adults of both genders.
- Patients who are free from any systemic disease (ASA I).
- Patients with teeth loss at upper anterior and premolar regions more than 1-year.
- Presence of sufficient apical and peripheral bone to achieve primary implant stability (minimum 3-5 mm of bone beyond the socket apex and overall socket length ≥ 10 mm).
- Patients with bone quality classified as D3, as assessed by pre-operative CBCT.
You may not qualify if:
- Pregnant and lactating women.
- Heavy smoking (\>10 cigarettes/day)
- Patients with bad oral habits such as bruxism.
- Patients with poor oral hygiene.
- Patients with gingival diseases.
- Patients with periodontal diseases (with severe vertical or horizontal bone loss).
- Teeth with periapical or lateral infection or lesions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suez Canal University, Faculty of Dentistry
Ismailia, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamed Said Hamed, Professor of Oral and Maxillof
Suez Canal University
- STUDY DIRECTOR
Ahmed Abdelmohsen Younis, Associate Professor of Oral an
Suez Canal University
- PRINCIPAL INVESTIGATOR
Mina Raafat, B.S.D
Suez Canal University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 12, 2026
First Posted
June 17, 2026
Study Start
January 10, 2025
Primary Completion
April 10, 2026
Study Completion
May 10, 2026
Last Updated
June 17, 2026
Record last verified: 2026-06